diabetes mellitus. -
Conditions
Interventions
Intervention 1: The intervation group will be 30 type 2 diabetic patients with retinopathy. They will consume two curcumin c power capsules ( 575 mg curcumin c and 25 mg bioperine purchased from As
Treatment - Drugs
Placebo
The intervation group will be 30 type 2 diabetic patients with retinopathy. They will consume two curcumin c power capsules ( 575 mg curcumin c and 25 mg bioperine purchased from Asmi Direct Market
The control group will be 30 type 2 diabetic patients wihtout retinopathy.They will match in terms of age and sex with case group.They will consume two cellulose capsule (sigma) between their meal fo
Sponsors
Diabetes Research Center of Yazd Shahid Sadoughi Univercity of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria age 40 to 60, history of diabetes less than 10 years, fasting blood glucose 130 to 200 mg%, 2 hours blood glucose 160 to 250mg%, type of medicine for controlling blood glucose: solphonyl urea and metformin. Exclusion criteria people who had surgery, pregnant and lactating women , no change in food habits and physical activity and consumption of medicines which effect on the blood lipids and glucose.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fructoseamine. Timepoint: before intervation and one and half month after intervation. Method of measurement: micromole per liter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Malondialdehyde. Timepoint: before intervation and one and half month after intervation. Method of measurement: nanomole per liter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNayereh Parsaeyan
Yazd Shahid Sadoughi University of Medical Sciences
Outcome results
None listed